These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 16273749)

  • 21. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gastropathy caused by nonsteroidal anti-inflammatory agents].
    Márquez-Murillo MF; Suazo J; Poo JL
    Rev Invest Clin; 1997; 49(3):241-54. PubMed ID: 9380979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
    Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ;
    J Am Coll Cardiol; 2008 Oct; 52(18):1502-17. PubMed ID: 19017521
    [No Abstract]   [Full Text] [Related]  

  • 26. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].
    Bar-Dayan Y; Levi Y
    Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose aspirin for everyone?
    Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
    [No Abstract]   [Full Text] [Related]  

  • 31. Daily low-dose aspirin: beware of GI bleeding.
    Johns Hopkins Med Lett Health After 50; 2012 Mar; 24(1):6. PubMed ID: 22493823
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of aspirin use with vitamin B12 deficiency (results of the BACH study).
    van Oijen MG; Laheij RJ; Peters WH; Jansen JB; Verheugt FW;
    Am J Cardiol; 2004 Oct; 94(7):975-7. PubMed ID: 15464695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HP eradication prevents recurrent hemorrhages caused by acetylsalicylic acid].
    Labenz J
    MMW Fortschr Med; 2013 Jun; 155(12):31. PubMed ID: 23923307
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding.
    Sung JJ
    Am J Med; 2001 Jan; 110(1A):29S-32S. PubMed ID: 11165993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey.
    Sbrozzi-Vanni A; Zullo A; Di Giulio E; Hassan C; Corleto VD; Lahner E; Annibale B
    Dig Liver Dis; 2010 Nov; 42(11):773-6. PubMed ID: 20444661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective COX-2 inhibitors: a promise unfulfilled?
    Henry D; McGettigan P
    Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
    [No Abstract]   [Full Text] [Related]  

  • 38. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
    Chitapanarux T; Lertprasertsuke N; Kongnak A
    Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
    Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
    Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management].
    Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG;
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.